tiprankstipranks
ArriVent Biopharma files automatic mixed securities shelf
PremiumThe FlyArriVent Biopharma files automatic mixed securities shelf
1M ago
ArriVent Biopharma price target raised to $39 from $36 at H.C. Wainwright
Premium
The Fly
ArriVent Biopharma price target raised to $39 from $36 at H.C. Wainwright
1M ago
Premium
Company Announcements
ArriVent BioPharma Expands Oncology Pipeline with New License
1M ago
ArriVent Biopharma price target raised to $36 from $30 at H.C. Wainwright
PremiumThe FlyArriVent Biopharma price target raised to $36 from $30 at H.C. Wainwright
6M ago
ArriVent announces PoC global Phase 1b interim data for firmonertinib
Premium
The Fly
ArriVent announces PoC global Phase 1b interim data for firmonertinib
6M ago
Corbus Pharmaceuticals appoints Kung to board of directors
Premium
The Fly
Corbus Pharmaceuticals appoints Kung to board of directors
7M ago
ArriVent Biopharma announces multi-target ADC collaboration with Alphamab
PremiumThe FlyArriVent Biopharma announces multi-target ADC collaboration with Alphamab
9M ago
Premium
Company Announcements
ArriVent BioPharma Welcomes Dr. Hohneker to Board
10M ago
ArriVent Biopharma reports Q1 EPS (70c), consensus ($1.10)
Premium
The Fly
ArriVent Biopharma reports Q1 EPS (70c), consensus ($1.10)
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100